%0 Journal Article
%T 阻塞性睡眠呼吸暂停低通气综合征治疗进展<br>Progress in the Treatment of Obstructive Sleep Apnea Hypoventilation Syndrome
%A 苗怡
%A 杜延玲
%J Advances in Clinical Medicine
%P 5018-5023
%@ 2161-8720
%D 2022
%I Hans Publishing
%R 10.12677/ACM.2022.126728
%X 阻塞性睡眠呼吸暂停低通气综合征(OSAHS)严重影响患者的日常生活，降低患者生活质量，增加患者其他疾病发病率和死亡率。是目前临床上较为常见的一种睡眠障碍、且与呼吸相关的疾病，现有大量研究表明，OSAHS与高血压、胰岛素抵抗、冠心病等多种疾病密切相关。准确评估患者病情，为OSAHS患者制定适宜的治疗方法显得尤为重要。本文简要概述了OSAHS的治疗措施。<br />
Obstructive sleep apnea hypopnea syndrome (OSAHS) seriously affects patients’ daily life, reduces the quality of life, and increases the morbidity and mortality of other diseases. It is a common clini-cal sleep disorder and breathing-related disease. A large number of existing studies show that OSAHS is closely related to hypertension, insulin resistance, coronary heart disease and other dis-eases. It is particularly important to accurately evaluate patients' condition and develop appropri-ate treatments for OSAHS patients. This paper provides a brief overview of the treatment measures for OSAHS.
%K 阻塞性睡眠呼吸暂停，治疗<br>Obstructive Sleep Apnea
%K Treatment
%U http://www.hanspub.org/journal/PaperInformation.aspx?PaperID=52226